March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
TG-Interacting Factors (TGIFs): A molecular target for corneal fibrosis modulation
Author Affiliations & Notes
  • Ajay Sharma
    Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S Truman VA hospital, Columbia, Missouri
  • Jason T. Rodier
    Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S Truman VA hospital, Columbia, Missouri
  • Ashish Tandon
    Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S Truman VA hospital, Columbia, Missouri
  • Rajiv R. Mohan
    Mason Eye Institute, University of Missouri, Columbia, Missouri
    Harry S Truman VA hospital, Columbia, Missouri
  • Footnotes
    Commercial Relationships  Ajay Sharma, None; Jason T. Rodier, None; Ashish Tandon, None; Rajiv R. Mohan, None
  • Footnotes
    Support  RO1EY17294; 1I01BX000357–01 (RRM) and Unrestricted Research to Prevent Blindness
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 3565. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ajay Sharma, Jason T. Rodier, Ashish Tandon, Rajiv R. Mohan; TG-Interacting Factors (TGIFs): A molecular target for corneal fibrosis modulation. Invest. Ophthalmol. Vis. Sci. 2012;53(14):3565.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Recently, we reported that histone deacetylase inhibitors such as trichostatin-A (TSA) and vorinostat inhibit fibrosis in the rabbit cornea in vivo. In our subsequent studies, we detected a simultaneous increase of TGIFs, the negative regulator of TGFβ, during TSA-mediated corneal fibrosis inhibition. It is yet unknown whether TGIFs increase a key step in TSA-mediated corneal fibrosis inhibition? We tested the hypothesis that anti-fibrotic effects of TSA are due to the TGIFs up-regulation using RNA knockdown approach.

Methods: : Human corneal fibroblasts (HCF) were generated from donor corneas. Cultures were treated with a vehicle, TGFβ1 (1ng/ml), TSA (500nM) or TGFβ1+TSA. To test the role of TGIF, HCF were transfected with TGIF-specific siRNA (50 pmol) using lipofectamine and then exposed to TGFβ1+TSA. Fibrosis parameters were quantified by analyzing the mRNA and protein levels of alpha smooth muscle actin (SMA) with real-time PCR and immunobloting. TGIF levels in cultures were measured with real-time PCR and immunoprecipitation.

Results: : TGFβ treatment of HCF caused robust fibrosis as indicated by a significant increase in mRNA and protein levels of SMA (4-7 fold). TGFβ also caused low transient increase in TGIFs mRNA (1.2-1.5 fold) presumably due to its feedback mechanism. TSA treatment significantly inhibited TGFβ-induced fibrosis as shown by a significant decrease in SMA mRNA and protein expression (60-75%±9; p<0.05-0.01) and coupled with a concurrent increase in TGIF expression (2.5-3.0 fold p<0.01) both in the presence and absence of TGFβ. siRNA transfection of HCF significantly inhibited TSA-induced TGIF increase (0.8-1.5 fold p<0.05) and reversed TSA-mediated inhibition of fibrosis as shown by notable increase in mRNA and protein levels of SMA.

Conclusions: : TSA-mediated increase in TGIFs is a critical step for attenuating corneal fibrosis. Our data also suggests that TGIFs could be a novel target to inhibit corneal fibrosis.

Keywords: cornea: stroma and keratocytes • cornea: basic science • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×